CYCSP25: A Drug Target / Disease Biomarker (G120528)

Target Name: CYCSP25

NCBI ID: G120528

CYCSP25

Other Name(s): HCP25 | CYCS pseudogene 25 | HC10 | Cytochrome c, somatic pseudogene 25

CYCSP25: A Drug Target / Disease Biomarker

CYCSP25 is a protein that is expressed in various tissues of the body, including the brain, heart, and liver. It is a member of the superfamily of cytoskeletal proteins, which are involved in the structure and function of cells. CYCSP25 is unique because it is able to interact with other proteins that are not related to cytoskeletal structures. This interaction between CYCSP25 and other proteins is important for its function in the development and progression of various diseases.

One of the key functions of CYCSP25 is its role in cell signaling. CYCSP25 is involved in the regulation of cell proliferation and differentiation, as well as in the formation of tight junctions between cells. This protein is able to interact with several different proteins that are involved in these processes, including the TGF-β1 receptor. TGF-β1 is a protein that is involved in the regulation of cell growth and differentiation, and it is thought to play a key role in the development of cancer.

Another function of CYCSP25 is its role in the regulation of cell migration. CYCSP25 is able to interact with several different proteins that are involved in cell migration, including the FAK receptor. FAK is a protein that is involved in the regulation of cell adhesion and migration, and it is thought to play a key role in the development of cancer.

In addition to its role in cell signaling and cell migration, CYCSP25 is also involved in the regulation of cell survival. CYCSP25 is able to interact with several different proteins that are involved in cell survival, including the BCL-2 protein. BCL-2 is a protein that is involved in the regulation of cell survival, and it is thought to play a key role in the development of cancer.

CYCSP25 is also involved in the regulation of inflammation. CYCSP25 is able to interact with several different proteins that are involved in inflammation, including the NF-kappa-B signaling pathway. NF-kappa-B is a signaling pathway that is involved in the regulation of inflammation and immune responses, and it is thought to play a key role in the development of many diseases.

Despite its many functions, CYCSP25 is not yet well understood. There are currently very few studies that have focused on the role of CYCSP25 in disease, and much of the research that has been done on this protein has been done in cell culture or in animal models of disease. There is a need for further research to fully understand the role of CYCSP25 in disease and to develop new treatments based on its properties.

In conclusion, CYCSP25 is a protein that is involved in a wide range of cell signaling and regulatory processes. Its unique ability to interact with other proteins makes it an important player in the development and progression of many diseases. Further research is needed to fully understand the role of CYCSP25 in disease and to develop new treatments based on its properties.

Protein Name: CYCS Pseudogene 25

The "CYCSP25 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CYCSP25 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets